Antimicrobial resistance (AMR) is the ability of microbes, including bacteria, viruses, and some parasites, to resist the effects of drugs, meaning that the germs are not only not killed, but there their growth is not inhibited. For obvious reasons, infections with resistant organisms are difficult to treat, requiring costly and sometimes toxic alternatives. While some people are at increased risk, no single person can avoid the risk of antibiotic-resistant infections altogether. Since organisms will always find a way to adapt and resist antibiotics, there is a heightened need to keep new resistance from developing and to prevent the resistance that already exists from spreading.
-
Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems...
Wastewater serves as a mirror of society, offering valuable insights into a wide range of parameters. Molecular biology leverages this potential by regular analysis of wastewater samples to...
The rising prevalence of sexually transmitted infections (STIs) and antimicrobial resistance (AMR) presents significant challenges to public health, necessitating robust policies and advance...
This session provides an overview of how the applications for infectious disease and microbiology on the MISeq i100 Series can support genomic surveillance for managing disease outbreaks, co...
Antipsychotic (AP) medications are increasingly recognised for their association with a heightened risk of infections. Clozapine, an atypical AP reserved for treatment-resistant schizophreni...
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
Acute cough is one of the most common reasons for consulting in primary care thus driving considerable antibiotic use and health-care costs. Currently, identification of microbial etiology i...